These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21824290)

  • 21. Self-assembly of Abeta(1-42) into globular neurotoxins.
    Chromy BA; Nowak RJ; Lambert MP; Viola KL; Chang L; Velasco PT; Jones BW; Fernandez SJ; Lacor PN; Horowitz P; Finch CE; Krafft GA; Klein WL
    Biochemistry; 2003 Nov; 42(44):12749-60. PubMed ID: 14596589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Globular and protofibrillar aβ aggregates impair neurotransmission by different mechanisms.
    Moreth J; Kroker KS; Schwanzar D; Schnack C; von Arnim CA; Hengerer B; Rosenbrock H; Kussmaul L
    Biochemistry; 2013 Feb; 52(8):1466-76. PubMed ID: 23374097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble aggregates of the amyloid-beta protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells.
    Gonzalez-Velasquez FJ; Moss MA
    J Neurochem; 2008 Jan; 104(2):500-13. PubMed ID: 17953673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small molecule beta-amyloid inhibitors that stabilize protofibrillar structures in vitro improve cognition and pathology in a mouse model of Alzheimer's disease.
    Hawkes CA; Deng LH; Shaw JE; Nitz M; McLaurin J
    Eur J Neurosci; 2010 Jan; 31(2):203-13. PubMed ID: 20074226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils.
    Arimon M; Grimminger V; Sanz F; Lashuel HA
    J Mol Biol; 2008 Dec; 384(5):1157-73. PubMed ID: 18851977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods for analysis of amyloid-β aggregates.
    Bruggink KA; Müller M; Kuiperij HB; Verbeek MM
    J Alzheimers Dis; 2012; 28(4):735-58. PubMed ID: 22156047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
    Lam AR; Teplow DB; Stanley HE; Urbanc B
    J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between amyloid beta-protein aggregates and membranes.
    Kakio A; Yano Y; Takai D; Kuroda Y; Matsumoto O; Kozutsumi Y; Matsuzaki K
    J Pept Sci; 2004 Oct; 10(10):612-21. PubMed ID: 15526710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment.
    Tjernberg LO; Tjernberg A; Bark N; Shi Y; Ruzsicska BP; Bu Z; Thyberg J; Callaway DJ
    Biochem J; 2002 Aug; 366(Pt 1):343-51. PubMed ID: 12023906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion.
    Kumar S; Mohanty SK; Udgaonkar JB
    J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
    Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
    J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the mutation A21G (Flemish variant) on Alzheimer's beta-amyloid dimers by molecular dynamics simulations.
    Huet A; Derreumaux P
    Biophys J; 2006 Nov; 91(10):3829-40. PubMed ID: 16891372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the stability of Alzheimer's amyloid protofibrils using molecular dynamics.
    Lemkul JA; Bevan DR
    J Phys Chem B; 2010 Feb; 114(4):1652-60. PubMed ID: 20055378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural characterization of a soluble amyloid beta-peptide oligomer.
    Yu L; Edalji R; Harlan JE; Holzman TF; Lopez AP; Labkovsky B; Hillen H; Barghorn S; Ebert U; Richardson PL; Miesbauer L; Solomon L; Bartley D; Walter K; Johnson RW; Hajduk PJ; Olejniczak ET
    Biochemistry; 2009 Mar; 48(9):1870-7. PubMed ID: 19216516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of human proteins to amyloid-β protofibrils.
    Rahman MM; Zetterberg H; Lendel C; Härd T
    ACS Chem Biol; 2015 Mar; 10(3):766-74. PubMed ID: 25469473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of neurotoxic tau oligomers.
    Lasagna-Reeves CA; Castillo-Carranza DL; Guerrero-Muoz MJ; Jackson GR; Kayed R
    Biochemistry; 2010 Nov; 49(47):10039-41. PubMed ID: 21047142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid-beta aggregation.
    Finder VH; Glockshuber R
    Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.